Effect of Cognitive Behavioral Therapy in Patients With Chronic Nonspecific Low Back Pain

Sponsor
Cairo University (Other)
Overall Status
Completed
CT.gov ID
NCT04938739
Collaborator
(none)
30
1
2
2.9
10.3

Study Details

Study Description

Brief Summary

The purpose of the study is to determine the effectiveness of cognitive-behavioral therapy on functional outcomes, pain, and pain-related anxiety in patients with chronic nonspecific low back pain

Condition or Disease Intervention/Treatment Phase
  • Other: Cognitive Behavioral Therapy
  • Other: Home program exercises
N/A

Detailed Description

Back pain has considerable negative effects on the quality of life of affected individuals. Individuals with new-onset back pain have an increased risk of lower quality of life scores, and the negative effect on quality of life increases with persistent pain. Patients with chronic back pain report a quality of life that is lower than individuals without pain and that is comparable to those of individuals with life-threatening diagnoses. In addition, back pain is associated with worry and fears, particularly about the (sense of) self and socialrelationships and especially when pain persists longer than expected.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Cognitive Behavioral Therapy in Patients With Chronic Nonspecific Low Back Pain
Actual Study Start Date :
Dec 1, 2020
Actual Primary Completion Date :
Jan 15, 2021
Actual Study Completion Date :
Feb 28, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive Behavioral therapy

to modify any erroneous beliefs about pain and disability and to promote coping strategies and self-efficacy through a graded activity.

Other: Cognitive Behavioral Therapy
The first 6 sessions: the cognitive part was explained with the support of a PowerPoint presentation using diagrams, images, and texts. The therapist explained the lumbar engine behavior, the neurophysiologic basis of pain, the importance of the participant's involvement in the treatment (e.g., coping and motivation), and the maintenance of good ergonomics which was aimed at modifying the physiologic response to the pain system. The second 12 sessions: concepts viewed in the first session were revised; as well, the operant and respondent parts were explained.

Other: Home program exercises
Each session will include 10 minutes of aerobic activity (walking or stationary bicycle), followed by five types of muscle stretches and eight types of ground exercises aimed at strengthening the lumbar muscles responsible for stabilization.

Active Comparator: Home program exercises

Patients in both groups carried out exercise therapy for six weeks. There will be an educational session for each patient to make sure the exercises will be done successfully and supervision once per week.

Other: Home program exercises
Each session will include 10 minutes of aerobic activity (walking or stationary bicycle), followed by five types of muscle stretches and eight types of ground exercises aimed at strengthening the lumbar muscles responsible for stabilization.

Outcome Measures

Primary Outcome Measures

  1. Assessing the change in pain intensity [Baseline and 6 weeks post-intervention]

    Assessment via using visual analogue scale A tool used to help a person rate the intensity of certain sensations and feelings, such as pain. The visual analog scale for pain is a straight line with one

  2. Assessing the change in back function [Baseline and 6 weeks post-intervention]

    Assessment via using Oswestry Low Back Pain Disability Index It is a 10-item self assessing questionnaire; each item contains 6 levels of answers that can be scored from 0 to 5.

Secondary Outcome Measures

  1. Assessing the change in anxiety related to pain [Baseline and 6 weeks post-intervention]

    Assessment via using pain anxiety symptom scale (PASS) is a 20-item self-report scale that measures components of pain-related anxiety, including cognitive anxiety, escape and avoidance, fearful appraisals of pain, and physiological anxiety.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Thirty patients with non-specific chronic low back pain from both sexes will be included.

  2. Subjects with normal body mass index (18 to 25).

  3. The age of patients range from 20 to 35 years.

  4. Duration of pain more than 3 months up to 2 years.

  5. Normal cognition score 26 or above according to MoCA Scale.7. Highly educated at least high school.

Exclusion Criteria:
The patients will be excluded if they have any of the followings:
  1. Lumbar canal stenosis.

  2. Lumbar discogenic lesions.

  3. Any inflammatory arthritis, tumors, infection involving the lumbar spine.

  4. Patients with decreased range of motion secondary to congenital anomalies, muscular contracture or bony block.

  5. Previous lumbar surgery or trauma.

  6. Subjects with a history of any neurologic disease.

  7. Cauda equina Syndrome.

  8. Patients suffering from psychological, cognitive or emotional disturbance.

  9. Patients who had previously participated in cognitive behavioral therapy.

  10. Deafness and blindness.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Outpatient clinic - Faculty of Physical Therapy - Cairo University Dokki Egypt 34518

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: Manar Abdelgalil, Abdelgalil, Horus University in Egypt

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Manar Abd El galil Aneis, Principal Investigator, Cairo University
ClinicalTrials.gov Identifier:
NCT04938739
Other Study ID Numbers:
  • Manis_MSc
First Posted:
Jun 24, 2021
Last Update Posted:
Jun 24, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 24, 2021